AC Immune (ACIU) EBITDA Margin Growth (3y) (2018 - 2025)
AC Immune (ACIU) EBITDA Margin Growth (3y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | AC Immune | 225.68 Mn | 225.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -137,641.00 |
| Sep 30, 2022 | -116,234.00 |
| Dec 31, 2020 | -214,886.00 |
| Sep 30, 2020 | 427.00 |
| Jun 30, 2020 | -11,123.00 |
| Mar 31, 2020 | 41,329.00 |
| Dec 31, 2019 | -310,418.00 |
| Sep 30, 2019 | 143,837.00 |
| Mar 31, 2019 | 126,784.00 |
| Dec 31, 2018 | -130,896.00 |
| Sep 30, 2018 | -60,732.00 |